Back to results
US 2021/0172023 A1Published application
Synthetic nucleic acid control molecules
AssigneeExact Sciences Development Company, LLC
InventorsIlse A. Tyler, Keith Yaeger, Michael J. Domanico, Hatim Allawi, Graham P. Lidgard
Life of this patent
Estimating the term…
Abstract
The present invention provides synthetic DNA strands that find use as controls or in nucleic acid testing methods. In particular, provided herein are synthetic DNA strands of known composition for use as control molecules in stool DNA testing, e.g., of mutations and/or methylation of DNA isolated from stool samples.
Claims21
1-78. (canceled)
A run control composition, comprising:
- a) a number of copies of a first synthetic DNA fragment, comprising:
- i) a methylation footprint nucleotide sequence of a human gene, the methylation footprint nucleotide sequence in said first synthetic DNA fragment comprising a pattern of cytosines, wherein each of the cytosines within the methylation footprint nucleotide sequence comprises a 5-methyl, and
- ii) a capture footprint nucleotide sequence;
- and
- b) a number of copies of a second synthetic DNA fragment comprising:
- i) the methylation footprint nucleotide sequence of the human gene, the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprising the same number and pattern of cytosines as the methylation footprint nucleotide sequence in the first synthetic DNA fragment, wherein none of the cytosines within the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprises a 5-methyl, and
- ii) the capture footprint nucleotide sequence;
- wherein a ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition produces a run control expected result when assayed in a methylation assay.
5 more elements
A method of characterizing a DNA test sample, comprising:
- A) providing a run control composition comprising:
- a) a first synthetic DNA fragment, comprising:
- i) a methylation footprint nucleotide sequence of a human gene, the methylation footprint nucleotide sequence in said first synthetic DNA fragment comprising a pattern of cytosines, wherein each of the cytosines within the methylation footprint nucleotide sequence comprises a 5-methyl, and
- ii) a capture footprint nucleotide sequence;
- and
- b) a second synthetic DNA fragment comprising:
- i) the methylation footprint nucleotide sequence of the human gene, the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprising the same number and pattern of cytosines as the methylation footprint nucleotide sequence in the first synthetic DNA fragment, wherein none of the cytosines within the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprises a 5-methyl, and
- ii) the capture footprint nucleotide sequence;
- wherein a ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition produces a run control expected result when assayed in a methylation assay;
- B) providing a DNA test sample isolated from a human subject;
- C) applying the methylation assay to the run control composition to produce run control experimental data;
- D) applying the methylation assay to the DNA test sample to produce test sample experimental data;
- and
- E) classifying the test sample experimental data as valid if the run control experimental data are within a pre-defined acceptable range relative to the run control expected result.
- wherein applying the methylation assay comprises processing the run control composition with a capture reagent comprising a capture probe that hybridizes to the capture footprint nucleotide sequence.
12 more elements
Dependencies are inferred from the claim text.